|
1
|
Louw L: Acquired cholesteatoma
pathogenesis: Stepwise explanations. J Laryngol Otol. 124:587–593.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Britze A, Moller ML and Ovesen T:
Incidence, 10-year recidivism rate and prognostic factors for
cholesteatoma. J Laryngol Otol. 131:319–328. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ergun S, Zheng X and Carlsoo B: Expression
of transforming growth factor-alpha and epidermal growth factor
receptor in middle ear cholesteatoma. Am J Otol. 17:393–396.
1996.PubMed/NCBI
|
|
4
|
Olszewska E, Wagner M, Bernal-Sprekelsen
M, Ebmeyer J, Dazert S, Hildmann H and Sudhoff H: Etiopathogenesis
of cholesteatoma. Eur Arch Otorhinolaryngol. 261:6–24. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kojima H, Shiwa M, Kamide Y and Moriyama
H: Expression and localization of mRNA for epidermal growth factor
and epidermal growth factor receptor in human cholesteatoma. Acta
Otolaryngol. 114:423–429. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kupper TS: The activated keratinocyte: A
model for inducible cytokine production by non-bone marrow-derived
cells in cutaneous inflammatory and immune responses. J Invest
Dermatol. 94 (6 Suppl):146s–150s. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Friedland DR, Eernisse R, Erbe C, Gupta N
and Cioffi JA: Cholesteatoma growth and proliferation:
Posttranscriptional regulation by microRNA-21. Otol Neurotol.
30:998–1005. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen X, Li X and Qin Z: MicroRNA-21
promotes the proliferation and invasion of cholesteatoma
keratinocytes. Acta Otolaryngol. 136:1261–1266. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang W, Chen X and Qin Z: MicroRNA let-7a
suppresses the growth and invasion of cholesteatoma keratinocytes.
Mol Med Rep. 11:2097–2103. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li N and Qin ZB: Inflammation-induced
miR-802 promotes cell proliferation in cholesteatoma. Biotechnol
Lett. 36:1753–1759. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen X and Qin Z: Post-transcriptional
regulation by microrna-21 and let-7a microRNA in paediatric
cholesteatoma. J Int Med Res. 39:2110–2118. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bak RO and Mikkelsen JG: miRNA sponges:
Soaking up miRNAs for regulation of gene expression. Wiley
Interdiscip Rev RNA. 5:317–333. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gao J, Tang Q, Zhu X, Wang S, Zhang Y, Liu
W, Gao Z and Yang H: Long noncoding RNAs show differential
expression profiles and display ceRNA potential in cholesteatoma
pathogenesis. Oncol Rep. 39:2091–2100. 2018.PubMed/NCBI
|
|
16
|
Jeck WR, Sorrentino JA, Wang K, Slevin MK,
Burd CE, Liu J, Marzluff WF and Sharpless NE: Circular RNAs are
abundant, conserved, and associated with ALU repeats. RNA.
19:141–157. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, Loewer A, et al: Circular RNAs are a large class of animal RNAs
with regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Salzman J, Gawad C, Wang PL, Lacayo N and
Brown PO: Circular RNAs are the predominant transcript isoform from
hundreds of human genes in diverse cell types. PLoS One.
7:e307332012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Starke S, Jost I, Rossbach O, Schneider T,
Schreiner S, Hung LH and Bindereif A: Exon circularization requires
canonical splice signals. Cell Rep. 10:103–111. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guo JU, Agarwal V, Guo H and Bartel DP:
Expanded identification and characterization of mammalian circular
RNAs. Genome Biol. 15:4092014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang M, Zhong Z, Lv M, Shu J, Tian Q and
Chen J: Comprehensive analysis of differentially expressed profiles
of lncRNAs and circRNAs with associated co-expression and ceRNA
networks in bladder carcinoma. Oncotarget. 7:47186–47200.
2016.PubMed/NCBI
|
|
23
|
Fan X, Weng X, Zhao Y, Chen W, Gan T and
Xu D: Circular RNAs in Cardiovascular Disease: An Overview. Biomed
Res Int. 2017:51357812017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang S, Zhu D, Li H, Li H, Feng C and
Zhang W: Characterization of circRNA-Associated-ceRNA networks in a
senescence-accelerated mouse prone 8 brain. Mol Ther. 25:2053–2061.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pasquinelli AE: MicroRNAs and their
targets: Recognition, regulation and an emerging reciprocal
relationship. Nat Rev Genet. 13:271–282. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Enright AJ, John B, Gaul U, Tuschl T,
Sander C and Marks DS: MicroRNA targets in Drosophila. Genome Biol.
5:R12003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
D'Angelo G, Capasso S, Sticco L and Russo
D: Glycosphingolipids: Synthesis and functions. FEBS J.
280:6338–6353. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Patel DD and Kuchroo VK: Th17 Cell Pathway
in Human Immunity: Lessons from genetics and therapeutic
interventions. Immunity. 43:1040–1051. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gray LR, Tompkins SC and Taylor EB:
Regulation of pyruvate metabolism and human disease. Cell Mol Life
Sci. 71:2577–2604. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Coelho AI, Berry GT and Rubio-Gozalbo ME:
Galactose metabolism and health. Curr Opin Clin Nutr Metab Care.
18:422–427. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kidd P: Th1/Th2 balance: The hypothesis,
its limitations, and implications for health and disease. Altern
Med Rev. 8:223–246. 2003.PubMed/NCBI
|
|
34
|
Kim EK and Choi EJ: Pathological roles of
MAPK signaling pathways in human diseases. Biochim Biophys Acta.
1802:396–405. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Johnson CD, Esquela-Kerscher A, Stefani G,
Byrom M, Kelnar K, Ovcharenko D, Wilson M, Wang X, Shelton J,
Shingara J, et al: The let-7 microRNA represses cell proliferation
pathways in human cells. Cancer Res. 67:7713–7722. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jeck WR and Sharpless NE: Detecting and
characterizing circular RNAs. Nat Biotechnol. 32:453–461. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ashwal-Fluss R, Meyer M, Pamudurti NR,
Ivanov A, Bartok O, Hanan M, Evantal N, Memczak S, Rajewsky N and
Kadener S: circRNA biogenesis competes with pre-mRNA splicing. Mol
Cell. 56:55–66. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lasda E and Parker R: Circular RNAs:
Diversity of form and function. RNA. 20:1829–1842. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ebbesen KK, Hansen TB and Kjems J:
Insights into circular RNA biology. RNA Bio. 14:1035–1045. 2017.
View Article : Google Scholar
|
|
40
|
Ecsedi S, Rakosy Z, Vizkeleti L, Juhász A,
Sziklai I, Adány R and Balázs M: Chromosomal imbalances are
associated with increased proliferation and might contribute to
bone destruction in cholesteatoma. Otolaryngol Head Neck Surg.
139:635–640. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Song G, Ouyang G and Bao S: The activation
of Akt/PKB signaling pathway and cell survival. J Cell Mol Med.
9:59–71. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Huisman MA, De Heer E and Grote JJ:
Survival signaling and terminal differentiation in cholesteatoma
epithelium. Acta Otolaryngol. 127:424–429. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yune TY and Byun JY: Expression of PTEN
and phosphorylated Akt in human cholesteatoma epithelium. Acta
Otolaryngol. 129:501–506. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hawkins PT, Anderson KE, Davidson K and
Stephens LR: Signalling through Class I PI3Ks in mammalian cells.
Biochem Soc Trans. 34:647–662. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lim LP, Lau NC, Weinstein EG, Abdelhakim
A, Yekta S, Rhoades MW, Burge CB and Bartel DP: The microRNAs of
Caenorhabditis elegans. Genes Dev. 17:991–1008. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Park SM, Shell S, Radjabi AR, Schickel R,
Feig C, Boyerinas B, Dinulescu DM, Lengyel E and Peter ME: Let-7
prevents early cancer progression by suppressing expression of the
embryonic gene HMGA2. Cell Cycle. 6:2585–2590. 2007. View Article : Google Scholar : PubMed/NCBI
|
